Rare diseases
Investigational molecules
Locations
Carretera Canyet 1a Planta, 08916 Badalona, Spain
Hospital Universitario Hermanos Trias y Pujol. Institut Catalá d'Oncología (ICO) in Badalona, Spain specialises in clinical trials of conditions such as Plasma cell myeloma, HIV infection, Non-small cell lung cancer, Dermatitis atopic, and other specialisations. This site conducts important research.
At Hospital Universitario Hermanos Trias y Pujol and the Institut Catalá d'Oncología (ICO) in Badalona, clinical research in oncology focuses on hemic and lymphatic diseases as well as immune system diseases. The studies are centered on improving treatment options for blood cancers, especially acute myeloid leukemia, while also exploring broader cancer-related care.
This research site is contributing to studies that aim to refine treatment strategies, strengthen response rates, and make care more effective for patients with complex blood-related cancers.
A major part of the trial activity at this site is dedicated to acute myeloid leukemia, with studies designed to test whether modified treatment approaches can maintain strong results while potentially improving tolerability. These trials are focused on patients who are not candidates for intensive induction therapy and seek to optimize real-world treatment effectiveness.
The research reflects a strong interest in finding practical, patient-friendly options for leukemia management, with a clear emphasis on response quality and clinical benefit.
The oncology program at this health care site includes trials aimed at advancing care for hemic and lymphatic diseases. The main goal is to evaluate whether updated treatment strategies can improve outcomes for people living with difficult-to-treat blood cancers, especially acute myeloid leukemia.
With multiple investigators involved, the site supports collaborative clinical research that aims to improve outcomes and inform more tailored approaches in oncology.
Clinical trials currently enrolling participants at this site.
Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD
SpainSpainLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
SpainOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
SpainBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
SpainA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
SpainStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
SpainA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
SpainLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
SpainA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
SpainA Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity
SpainStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
